ASCENTAGE PHARMA Group Acquires 110,000 Shares for 2022 Restricted Stock Unit Plan
Stock News
Jun 11
The trustee for ASCENTAGE PHARMA GROUP (ASX: AAPG) has purchased a total of 110,000 existing shares on the market.
This transaction, conducted on June 11, 2026, was executed to fulfill obligations under the company's 2022 Restricted Stock Unit Plan upon the vesting of those units.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.